Aim: Oxysterols are found in high concentrations in advanced atherosclerotic plaques and are considered as an important factor in the development of vascular calcification. The purpose of this study was to investigate the effect of 7-ketocholesterol (7kc), a major oxysterol in plaques, on in vitro arterial calcification. 
and, of special note, vascular calcification causes the functional disturbance of organs with increased risk of cardiac infarction. It is known that almost half of the cause of death in dialysis patients is attributed to cardiovascular disease. Consequently, it is assumed that vascular calcification in patients with renal disease is a serious problem from a clinical point of view.
Lipid metabolism abnormality is known as a major risk factor of atherosclerosis 3) . Depositions of calcium phosphate have been observed on advanced atherosclerotic lesions in humans 4) or apolipoprotein-E (ApoE)-null mice 5) . Calcification of aortic valve leaflets and atherosclerotic plaques have long been recognized as clinically important. Oxidation of low-density lipoprotein (LDL) is thought to play an important role in the development of atherosclerosis. Oxysterols are associated with the cytotoxicity of oxidized LDL (oxLDL) and are found in high concentrations in
Introduction
Pathological mineralization of the vascular system, kidneys and heart, unlike bone mineralization, is called ectopic calcification, which is promoted by advanced age, vascular inflammation, and certain metabolic disorders 1) . Vascular calcification is a common event in the pathogenesis of arteriosclerosis in dialysis patients and has been positively correlated with an increased risk of myocardial infarction 2) . The development of calcification impairs organizational flexibility advanced atherosclerotic plaqes 6) , especially in foam cells around the necrotic core 7) , and accelerate arterial calcification via the induction of apoptosis on arterial smooth muscle cells (SMC) 8) . 7-ketocholesterol (7kc), a major oxysterol in plaques, induces vascular SMC death with features of apoptosis, such as nuclear condensation and internucleosomal DNA fragmentation 9) , through caspase 3 activation 10) . An in vitro vascular calcification model has been developed as a useful model for analyzing the cellular mechanisms of calcification 11, 12) . In this calcification model, the addition of inorganic phosphate or -glycerophosphate is used to induce calcium deposition. Employing this system, we previously reported that elastic fiber components were down-regulated by the treatment of vascular calcification in cultured bovine VSMCs 11) . In addition, Pi-induced in vitro vascular calcification showed a similar association of vascular calcification with phenotypic transition from SMC to bone-and chondrocyte-like cells to osteogenic cells by various markers with gene expression, such as osteopontin (OPN) 13) , core binding factor 1 (Cbfa1) 14) , SM22-alpha 14, 15) , and alpha-smooth muscle actin (ACTA) 14, 15) . In the present study, we show that 7kc accelerates in vitro vascular calcification on a Pi-induced vascular calcification model. We also demonstrate the mechanisms of accelerated calcification by 7kc, including the Rho-ROCK signaling pathway and apoptosis.
Materials and Methods

Materials
Bovine VSMCs were purchased from Coriell Cell Repositories (Ref. No. AG08504). 7-ketocholesterol and risedronate were purchased from Sigma (St. Louis, MO, USA) and LKT Laboratories, Inc. (St. Paul, MN, USA), respectively. Calphostin C, protein kinase C (PKC) inhibitor, KT5720, protein kinase A (PKA) inhibitor, and KT5823, protein kinase G (PKG) inhibitor, were purchased from Calbiochem (San Diego, CA, USA). Y-27632, mitogen-activated protein kinase (MAPK) inhibitor, was purchased from Wako Pure Chemical Industries (Osaka, Japan). Dulbecco's modified Eagle's medium (DMEM), fetal bovine serum (FBS), penicillin/streptomycin, L-glutamine, nonessential amino acids, and sodium pyruvate were purchased from Invitrogen (Carlsbad, CA, USA).
Cell Culture and Induction of in vitro Calcification
VSMCs were cultured in DMEM containing 4.5 g/L glucose supplemented with 10% FBS, 0.1 mM non-essential amino acids, 2 mM L-glutamine, 100 unit/mL penicillin, and 100 g/mL streptomycin and were grown to confluent density. In vitro vascular calcification was induced as previously described 12, 16) , with slight modification. Briefly, confluent cells were incubated in DMEM containing 4.5 g/L glucose supplemented with 10% FBS in the presence of Pi (3 mM). In several experiments, VSMCs were treated with Y-27632 (10 5 M) or risedronate (10 6 M) in the presence of 7kc (1-4 g/mL) and/or Pi (3 mM). The initial day of culture in Pi-containing media was defined as day 0. The medium was changed every 2 days.
Calcium Deposition Assay
Cells were washed two times with tris-buffered saline and were treated in 0.6 N HCl for 24 h. Calcium concentrations in the HCl suprernatant were determined by Calcium C-test Wako (Wako Pure Chemical Industries, Osaka, Japan) as previously described 12, 16) . Each cell layer was washed with trisbuffered saline and solubilized with 0.1 N NaOH containing 0.1% sodium dodecyl sulfate (SDS). The protein concentrations in solubilized cells were measured with a MicroBCA protein assay kit (Pierce, Rockford, IL, USA). The calcium content of each cell layer was normalized by the protein content. Calcium phosphate deposition was assessed by von Kossa staining. Cells were fixed with 3.5% formaldehyde solution, and then treated with 5% silver nitrate solution for 30 min under ultraviolet irradiation to detect the calcium phosphate deposition.
RNA Isolation and Semi-Quantitative RT-PCR
RNA isolation and semi-quantitative reverse transcription-polymerase chain reaction (RT-PCR) were performed as described previously. RT-PCR was carried out using primers 5'-CACTCTCCATCTCTAG-GGGAACTTG-3' (forward) and 5'-GGAGAAGTGC-TAATGAAGTACAGTG-3' (reverse) to amplify nucleotide position 2536-3176 in the TE gene (GenBank accession no. J02717); primers 5'-ATCCACGAGAC-CACGTACAAC-3' (forward) and 5'-ATTCAAACCT-TGGGCTAGGAA-3' (reverse) to amplify nucleotide position 869-1281 in the ACTA2 gene (GenBank accession no. BT021508); primers 5'-GATTTGCTT-CTGCCTCTTGG-3' (forward) and 5'-ACACTATC-ACCTCGGCCATC-3' (reverse) to amplify nucleotide position 78-530 in the OPN gene (GenBank accession no. M66236); primers 5'-AACAGGATTGGT-GCTTTTGG-3' (forward) and 5'-AGTGCAGAG-GAGGGCTGTTA-3' (reverse) to amplify nucleotide position 682-1049 in the RhoA gene (GenBank accession no. NM_176645). 5'-CCGCACGACAACCGC-132 ACCAT-3' (forward) and 5'-CGCTCCGGCCCACA-AATCTC-3' (reverse) to amplify in the Cbfa1 gene 14) . Each cycle consisted of denaturing at 94 for 30 s, annealing for 30 s, and primer extension at 72 for 30 s; this was performed for 19 (RhoA), 20 (OPN), 21 (TE), 25 (ACTA2) or 26 (Cbfa1) cycles, with a final extension step at 72 for 10 min. Glyceraldehyde-3-phosphate dehydrogenase (GAPDH; GenBank accession no. AJ000039) was used as an internal control; the same amplification protocol (20 cycles) and the upstream primer 5'-ATCAATGACCCCTTCATT-GACC-3' and the downstream primer 5'-ATACTTG-GCAGGTTTCTCCAGG-3' were used to amplify nucleotide position 61-729. The resulting PCR products were separated by electrophoresis on 2% agarose gels and were visualized by ethidium bromide staining.
In situ Visualization of Apoptotic DNA Fragmentation
In situ visualization of DNA fragmentation was performed by the TdT-mediated dUTP nick end labeling (TUNEL) method with the use of an In Situ Cell Detection Kit, Fluorescein (Roche, Basel, Switzerland). VSMCs were cultured according to the a forementioned method, washed twice in phosphate-buffered saline (PBS) and fixed at room temperature for an hour with 4% paraformaldehyde-PBS solution. After fixation, cells were washed twice in PBS, permeabilized on ice for 2 minutes with 0.1% Triton X-100, 0.1% sodium citrate solution, and washed twice in PBS. Cells were incubated with TUNEL solution for an hour in 37 in a humidified atmosphere. After incubation, cells were washed three times in PBS and mounted in glycerol containing sodium phosphate and citric acid (Sigma, St. Louis, USA) and coverslipped. Apoptotic nuclei were visualized with a KEY-ENCE microscope with epifluorescence using 20 phase/fluorescence objectives.
Statistical Analysis
Data were statistically analyzed using ANOVA with post hoc Bonferroni/Dunn's analysis. The results were considered statistically significant when the P value was 0.05 ( p 0.05). All data are shown as the mean value SEM (standard error of the mean). All assays were performed in triplicate and repeated at least twice to confirm observed results.
Results
7kc Enhances Calcium Depositions in Pi-Induced Vascular Calcification of Bovine VSMCs
We examined the effects of 7kc on Pi-induced vascular calcification of bovine VSMCs. In the presence of Pi, von Kossa staining shows that 7kc significantly enhanced calcium deposition in a dose-dependent manner (Fig. 1) . We also quantitatively deter- Bovine VSMCs were cultured for 6 days with Pi (3 mM) in the presence of 7kc (1-4 g/mL). Calcified cells were stained using von Kossa staining. Magnification: 100. mined that calcium contents increased approximately 3.5-fold by treatment with 7kc (4 g/mL) in the presence of Pi (3 mM) (Fig. 2) . These results suggest that 7kc is able to induce vascular calcification in the presence of Pi.
Risedronate and Y-27632 Inhibit Calcium Deposition Induced by Pi and 7kc
In order to confirm the intracellular signaling pathway on 7kc-induced vascular calcification, VSMCs was incubated with risedronate or various protein kinase inhibitors in Pi-induced vascular calcification in the presence or absence of 7kc. Treatment with risedronate (RD) completely inhibited calcium depositions induced by Pi in both the presence and absence of 7kc (Fig. 3A) . On the other hand, treatment with Y-27632, a MAPK inhibitor, significantly reduced the calcium deposition induced by 7kc in the presence of Pi, but not Pi alone (Fig. 3B, C) .
Phenotypic Change of VSMCs in 7kc and PiInduced Vascular Calcification
It is known that osteoblastic differentiation markers, OPN 13) and Cbfa1/Runx2 14) , and smooth muscle lineage markers, SM22-alpha and ACTA 14, 15) , increase and reduce, respectively, with the phenotypic change of calcified VSMCs. We also previously reported that the expression of TE, a component and precursor protein of elastic fiber, declined on vascular calcification and, according to the addition of recombinant TE protein to calcified vascular smooth muscle cells, cal- cium deposition was suppressed 16) . 7kc dose-dependently stimulated the mRNA expression of OPN and Cbfa1 in the presence of Pi. On the other hand, the mRNA expression of TE and ACTA2 was suppressed by treatment with 7kc in a dose-dependent manner (Fig. 4) . The increase of expression of Rho A mRNA by treatment with 7kc in the presence of Pi is of particular interest (Fig. 4) .
We also confirmed whether the phenotypic change of SMCs by treatment with 7kc in the presence of Pi contributes to the mevalonate pathway or Rho-ROCK signaling pathway. Our present data showed that the expression of osteoblastic differentiation markers and smooth muscle lineage markers are restored in treatment with RD or Y-27632 (Fig. 5) .
7kc Induces Apoptosis in the Presence of Pi Via the Rho-ROCK Signaling Pathway
To understand the relationship between calcification induced by 7kc in the presence of Pi and apoptosis, we determined the apoptosis of cells using in situ DNA fragmentation assay. Our observation indicated that 7kc in the presence of Pi, but not 7kc alone, significantly induced apoptosis of VSMCs (Fig. 6A, B, E,  F) . We also confirmed that Y-27632, ROCK inhibitor, Bovine VSMCs were cultured for 6 days with Pi (3 mM) in the presence of 7kc (1-4 g/mL), and total RNA was then isolated by extraction in phenol/chloroform. RT-PCR was carried out using specific primers for bovine TE, ACTA2, OPN, Cbfa1 RhoA and GAPDH, which were analyzed by electrophoresis on 2% agarose gels and visualized by ethidium bromide staining. Bovine VSMCs were treated with RD (10 6 M) (A) or Y-27632 (10 5 M) (B) on vascular calcification induced by 7kc (4 g/mL) in the presence of Pi (3 mM), and total RNA was then isolated by extraction in phenol/chloroform. RT-PCR was carried out using specific primers for bovine TE, ACTA2, OPN, Cbfa1 and GAPDH, which were analyzed by electrophoresis on 2% agarose gels and visualized by ethidium bromide staining. inhibited the apoptosis of VSMCs, which is induced by treatment with 7kc and Pi (Fig. 6C, D, G, H) .
Discussion
The presence of calcium deposits in the vessel wall is indicative of advanced atherosclerosis, and the extent of coronary calcification has been found to add incremental prognostic significance to conventional risk factors for coronary artery disease 17, 18) . Arterial calcification causes a reduction in elasticity of the vessel wall and reduced compliance. Recently, we reported that vitamin K2 in combination with pamidronate, a bisphosphonate, synergistically inhibits vascular calcification using an in vitro Pi-induced calcification model 19) . Bisphosphonates are used as medicine mainly to inhibit bone resorption in diseases, such as osteoporosis, Paget's disease and tumor bone disease 20) . Bisphosphonates are also known to inhibit farnesylpyrophosphate (FPP) synthase of the mevalonate pathway in a similar manner to statins, which inhibit hydroxymethylglutaryl-CoA (HMG-CoA) reductase 21, 22) . The lack of geranylgeranylpyrophosphate of various small guanosine 5'-triphosphate (GTP)-binding proteins, including Rho, Ras, and Rab, thereby possibly impairs several cellular functions that these proteins regulate 23) ; however, it has been reported that bisphosphonates induce inflammation and rupture of atherosclerotic plaques using ApoE-null mice 24) . This observation suggests that bisphosphonates need to be focused on in therapeutic treatment for serious atherosclerosis with calcification.
The cores of advanced atherosclerotic lesions have been shown to contain lipid deposits and apoptotic SMC, which relate to plaque rupture 25) . Fibrosis also occurs as atherosclerosis progresses, often yielding a lesion containing a dense, extracellular matrix with relatively low cell density 25, 26) . Although in latter processes cell death provides a means for the conversion of a hypercellular lesion to a more fibrotic atheroma, little is known about the agents inducing cell death in the vascular wall and about its mechanisms. It has been reported that 7kc, a major oxysterol, is a potent inducer of SMC death characterized by loss of cell adhesion, modification of actin organization, decrease in mitochondrial transmembrane potential, and condensation or fragmentation of the nucleus 9) . We considered that apoptosis of VSMC is not induced by treatment with 7kc alone because we used a lower concentration of 7kc (4 g/mL) in comparison with the concentrations used in other study to induce apoptosis 27) . Recently, it has been reported that Pi induces calcification and apoptosis of VSMC 27, 28) . Our data indicated that 7kc in the presence of Pi significantly accelerates the vascular calcification and apoptosis of VSMC induced by Pi alone. Taken together, these The ability to undergo reversible differentiation is characteristic of the phenotypic change of SMC; these cells are in their differentiated, contractile form at baseline but responded to various stimuli by entering a proliferative, synthetic state to produce extracellular matrix 29) . As the atherosclerotic lesion progresses to fibrocalcific plaque, contained markers of osteogenic differentiation begin to be expressed, such as Cbfa1 14) or OPN 13) . Conversely, smooth muscle lineage markers SM22-alpha 14, 15) and ACTA 14, 15) are reduced. Our data indicated that treatment with RD or Y-27632 restored the expression of osteoblastic differentiation markers and smooth muscle lineage markers on vascular calcification induced by 7kc in the presence of Pi. These results suggest that osteogenic differentiation of SMC contributes to the Rho-ROCK signaling pathway in 7kc in the presence of Pi progress.
In conclusion, we have shown that 7kc, a major oxysterol, significantly accelerates vascular calcification, including calcium deposition, osteogenesis of SMC, and apoptosis in the presence of Pi via the Rho-ROCK signaling pathway. Chronic kidney disease patients are high-risk patients for atherosclerosis with vascular calcification. These patients are well recognized as having advanced arteriosclerosis with vascular medial calcification, with a high risk of cardiovascular death 30) . Our findings suggest that the 7kc and Pi levels in human plasma are an important parameter for vascular calcification. Moreover, our data provide beneficial information on the development of therapeutic approach for vascular calcification in patients with a mineral imbalance caused by kidney disease, including hypocalcaemia, hyperphosphatemia, and hypercholesterolemia.
